Insulet’s Omnipod Horizon AID (automated insulin delivery) is due to work with Abbott and Dexcom CGMs. Insulet’s partnerships with these two continuous glucose monitor companies means that is has plans to integrate Abbott’s FreeStyle Libre 2 (and Dexcom’s G6 (and upcoming G7, due to launch in 2021), into Insulet’s Omnipod Horizon automated insulin delivery (AID) system (launch in early 2021). AID systems use CGM and smart algorithms to automatically adjust insulin delivery via pump. The two partnerships mean that Horizon will be the first AID system with two CGM partners.
Both CGMs will be combined with Insulet’s AID system to predict blood glucose levels and dose insulin with the aim of keeping users within their target range.
The Omnipod Horizon system uses CGM readings to automatically adjust basal insulin delivery. Insulet’s tubeless insulin delivery pod is a three-day-wear patch pump, which will communicate with a CGM to deliver insulin. Users control the system directly from their smartphone.
Read more HERE.
